Theragen Etex Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
90,731
89,743
98,884
101,283
107,592
Cost of Goods Sold (COGS) incl. D&A
60,859
58,442
63,633
70,655
75,701
Gross Income
29,871
31,301
35,252
30,628
31,891
SG&A Expense
27,214
29,652
34,413
29,172
31,654
EBIT
2,103
-
544
-
237
Unusual Expense
852
102
-
-
551
Non Operating Income/Expense
108
247
4,532
1,473
2,345
Interest Expense
871
644
586
955
990
Pretax Income
836
1,198
4,273
1,525
869
Income Tax
639
313
2,849
324
282
Equity in Affiliates
20
16
38
-
-
Consolidated Net Income
1,456
1,527
7,160
1,849
1,151
Net Income
1,327
1,479
6,803
2,043
1,274
Net Income After Extraordinaries
1,327
1,360
5,435
1,857
1,274
Net Income Available to Common
1,327
1,598
8,171
2,043
1,274
EPS (Basic)
49.00
58.00
299.00
81.45
45.00
Basic Shares Outstanding
27
27
27
27
29
EPS (Diluted)
49.40
58.49
299.04
81.45
44.53
Diluted Shares Outstanding
27
27
27
27
29
EBITDA
5,494
4,207
3,104
3,840
3,129
Other Operating Expense
554
248
294
-
-
Non-Operating Interest Income
563
295
301
193
201
Minority Interest Expense
129
48
357
194
122
Equity in Affiliates (Pretax)
-
-
-
643
372

About Theragen Etex Co.

View Profile
Address
58 Sandan-ro 68beon-gil
Ansan-si GY 15438
Korea, Republic Of
Employees -
Website http://www.theragenetex.com
Updated 09/14/2018
THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical and Bio Businesses. The Pharmaceutical Business provides professional pharmaceutical products and new drugs development.